ERBB2 and breast cancer: MAF1 mRNA expression is significantly altered in luminal (p = 1.68 x 10−5) and triple-negative breast cancer (TNBC) (p = 2.01 x 10−7) but not in HER2-positive breast cancer, Fig 2A.